Goldman Sachs’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $308K | Sell |
325,746
-29,406
| -8% | -$27.8K | ﹤0.01% | 4516 |
|
|
2025
Q1 | $164K | Sell |
355,152
-185,055
| -34% | -$85.3K | ﹤0.01% | 4715 |
|
|
2024
Q4 | $399K | Buy |
540,207
+138,916
| +35% | +$103K | ﹤0.01% | 4402 |
|
|
2024
Q3 | $630K | Buy |
401,291
+27,860
| +7% | +$43.7K | ﹤0.01% | 3997 |
|
|
2024
Q2 | $627K | Buy |
373,431
+217,217
| +139% | +$365K | ﹤0.01% | 3834 |
|
|
2024
Q1 | $375K | Sell |
156,214
-79,125
| -34% | -$190K | ﹤0.01% | 4107 |
|
|
2023
Q4 | $360K | Sell |
235,339
-124,372
| -35% | -$190K | ﹤0.01% | 4094 |
|
|
2023
Q3 | $392K | Sell |
359,711
-193,297
| -35% | -$211K | ﹤0.01% | 3980 |
|
|
2023
Q2 | $1.27M | Buy |
553,008
+264,070
| +91% | +$605K | ﹤0.01% | 3476 |
|
|
2023
Q1 | $702K | Buy |
288,938
+22,581
| +8% | +$54.9K | ﹤0.01% | 3887 |
|
|
2022
Q4 | $509K | Buy |
266,357
+25,436
| +11% | +$48.6K | ﹤0.01% | 4079 |
|
|
2022
Q3 | $578K | Buy |
240,921
+32,896
| +16% | +$78.9K | ﹤0.01% | 4153 |
|
|
2022
Q2 | $387K | Buy |
208,025
+25,354
| +14% | +$47.2K | ﹤0.01% | 4547 |
|
|
2022
Q1 | $381K | Buy |
182,671
+25,189
| +16% | +$52.5K | ﹤0.01% | 4748 |
|
|
2021
Q4 | $621K | Buy |
157,482
+67,569
| +75% | +$266K | ﹤0.01% | 4377 |
|
|
2021
Q3 | $432K | Buy |
89,913
+18,925
| +27% | +$90.9K | ﹤0.01% | 4462 |
|
|
2021
Q2 | $326K | Buy |
70,988
+5,929
| +9% | +$27.2K | ﹤0.01% | 4661 |
|
|
2021
Q1 | $382K | Sell |
65,059
-8,297
| -11% | -$48.7K | ﹤0.01% | 4516 |
|
|
2020
Q4 | $250K | Sell |
73,356
-68,139
| -48% | -$232K | ﹤0.01% | 4165 |
|
|
2020
Q3 | $203K | Sell |
141,495
-374,647
| -73% | -$537K | ﹤0.01% | 4055 |
|
|
2020
Q2 | $1.03M | Buy |
516,142
+314,823
| +156% | +$628K | ﹤0.01% | 3203 |
|
|
2020
Q1 | $392K | Buy |
201,319
+56,927
| +39% | +$111K | ﹤0.01% | 3615 |
|
|
2019
Q4 | $599K | Sell |
144,392
-39,720
| -22% | -$165K | ﹤0.01% | 3563 |
|
|
2019
Q3 | $554K | Buy |
184,112
+66,801
| +57% | +$201K | ﹤0.01% | 3550 |
|
|
2019
Q2 | $738K | Buy |
117,311
+1,412
| +1% | +$8.88K | ﹤0.01% | 3341 |
|
|
2019
Q1 | $644K | Buy |
115,899
+10,806
| +10% | +$60K | ﹤0.01% | 3450 |
|
|
2018
Q4 | $698K | Sell |
105,093
-4,565
| -4% | -$30.3K | ﹤0.01% | 3287 |
|
|
2018
Q3 | $1.17M | Sell |
109,658
-5,730
| -5% | -$61.1K | ﹤0.01% | 3115 |
|
|
2018
Q2 | $1.39M | Buy |
115,388
+47,899
| +71% | +$575K | ﹤0.01% | 3047 |
|
|
2018
Q1 | $578K | Sell |
67,489
-66,753
| -50% | -$572K | ﹤0.01% | 3432 |
|
|
2017
Q4 | $1.33M | Sell |
134,242
-110,094
| -45% | -$1.09M | ﹤0.01% | 3036 |
|
|
2017
Q3 | $3M | Buy |
244,336
+110,293
| +82% | +$1.36M | ﹤0.01% | 2651 |
|
|
2017
Q2 | $2.21M | Buy |
134,043
+20,379
| +18% | +$335K | ﹤0.01% | 2750 |
|
|
2017
Q1 | $1.63M | Sell |
113,664
-56,244
| -33% | -$806K | ﹤0.01% | 2855 |
|
|
2016
Q4 | $2.35M | Buy |
169,908
+46,581
| +38% | +$644K | ﹤0.01% | 2615 |
|
|
2016
Q3 | $2.23M | Buy |
123,327
+40,317
| +49% | +$729K | ﹤0.01% | 2647 |
|
|
2016
Q2 | $1.19M | Sell |
83,010
-104,826
| -56% | -$1.5M | ﹤0.01% | 2862 |
|
|
2016
Q1 | $2.25M | Buy |
187,836
+75,360
| +67% | +$901K | ﹤0.01% | 2454 |
|
|
2015
Q4 | $1.5M | Sell |
112,476
-420,929
| -79% | -$5.6M | ﹤0.01% | 2676 |
|
|
2015
Q3 | $5.73M | Buy |
533,405
+511,904
| +2,381% | +$5.5M | ﹤0.01% | 1940 |
|
|
2015
Q2 | $173K | Sell |
21,501
-6,057
| -22% | -$48.7K | ﹤0.01% | 4086 |
|
|
2015
Q1 | $182K | Sell |
27,558
-22,004
| -44% | -$145K | ﹤0.01% | 3929 |
|
|
2014
Q4 | $316K | Buy |
49,562
+37,297
| +304% | +$238K | ﹤0.01% | 3664 |
|
|
2014
Q3 | $121K | Buy |
12,265
+164
| +1% | +$1.62K | ﹤0.01% | 4173 |
|
|
2014
Q2 | $136K | Buy |
12,101
+1,841
| +18% | +$20.7K | ﹤0.01% | 4117 |
|
|
2014
Q1 | $124K | Sell |
10,260
-21,086
| -67% | -$255K | ﹤0.01% | 4097 |
|
|
2013
Q4 | $395K | Sell |
31,346
-6,923
| -18% | -$87.2K | ﹤0.01% | 3549 |
|
|
2013
Q3 | $637K | Buy |
38,269
+26,189
| +217% | +$436K | ﹤0.01% | 3199 |
|
|
2013
Q2 | $183K | Buy |
+12,080
| New | +$183K | ﹤0.01% | 3667 |
|